<DOC>
	<DOCNO>NCT02637895</DOCNO>
	<brief_summary>Post-traumatic stress disorder ( PTSD ) result experience witness traumatic event . Patients PTSD symptom sometimes experience symptom relief treatment antidepressant ; however , patient experience complete symptom relief . There need develop new treatment PTSD . This study evaluate 12 week use Vortioxetine relieve PTSD symptom . Vortioxetine approve treatment depression ; however , Vortioxetine approve Food Drug Administration treatment PTSD .</brief_summary>
	<brief_title>Vortioxetine Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Patients include study either take study medication take placebo , pill without active medication . This determine chance like flip coin . Study procedures include take study medication come regular in-clinic visit . Depending study visit , study test may include follow : medical evaluation , physical exam , body measurement , vital sign , blood urine test , pregnancy test , genetic testing , heart function monitoring , clinical psychiatric measure , neuropsychological testing ( example , investigator test well remember word fast perform certain task ) , function test ( example , investigator test well perform certain daily task ) , test measure startle response . A startle response unexpected response sudden activity .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>Inclusion 1 . Males Females age 18 65 2 . Fulfills DSM5 criterion primary diagnosis PTSD . 3 . Able give consent 4 . Willingness sign treatment contract 5 . A negative urine toxicology 6 . For female reproductive age , use effective birth control method* duration study abstinence . 7 . Duration illness PTSD least 3 month 8 . An initial score Screening , Visit 3 ( randomization ) â‰¥ 50 CAPS PTSD Studies Exclusion 1 . Lifetime current diagnosis schizophrenia psychotic disorder , dementia , bipolar disorder . 2 . Subject currently participate another clinical trial s/he expose investigational noninvestigational drug device , do within precede month . 3 . Current evidence history significant unstable medical illness organic brain impairment , include stroke , CNS tumor , demyelinate disease , cardiac , pulmonary , gastrointestinal , renal hepatic impairment would likely interfere action , absorption , distribution , metabolism , excretion Vortioxetine . History moderate severe TBI also exclusionary . 4 . Patients investigator 's judgment pose current suicidal homicidal risk 5 . DSM5 substance abuse dependence within past 90 day . Subject positive urine toxicology test illegal substance . 6 . Diagnosis anorexia nervosa , bulimia , OCD past year . 7 . Subject documented history hepatobiliary disease include history , positive laboratory result hepatitis ( hepatitis B surface antigen and/or hepatitis C antibody ) , clinically significant hepatic enzyme elevation , include one follow enzymes great 3 time upper limit normal ( ULN ) value ( ALT , AST , ALP ) , total direct bil &gt; 1.5 x ULN , unless consistent presumed diagnose Gilbert 's disease 8 . Subject take systemic corticosteroid within 2 week Randomization Visit 9 . Treatment psychoactive medication within 2 week Visit 1 , include antidepressant , psychoactive herbal nutritional treatment ( St Johns Wort , SAMe ) , lithium , mood stabilizer , oral antipsychotic , depot antipsychotic within 12 week , beta blocker , thioridazine , pimozide , opiates , anxiolytic , sedative ( exception zolpidem , eszopiclone , zaleplon ) . Also treatment medication PI judge acceptable study . 10 . Pregnancy lactation* 11 . Subjects , opinion investigator , would noncompliant visit schedule study procedure ( e.g . illiteracy , plan vacation , plan hospitalization study ) . 12 . Any laboratory abnormality investigator 's judgment consider clinically significant ( blood pressure , ECG , TSH , LFT , etc . ) 13 . Patients receive exposurebased psychotherapy target PTSD symptoms 14 . Current planned litigation action related secondary gain regard traumatic event 15 . Subject clinical evidence , ECG result indicate follow either screen Randomization Visit unless repeat ECG show parameter return within normal range Randomization Visit : QTc &gt; 450 msec men , &gt; 475 msec woman ; cardiac condition ECG evidence investigator feel may pose potential safety concern .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>PTSD ,</keyword>
	<keyword>trauma</keyword>
	<keyword>stress disorder</keyword>
	<keyword>post-traumatic stress disorder</keyword>
	<keyword>anxiety disorder</keyword>
</DOC>